UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Análisis coste-efectividad de las principales herramientas diagnósticas en mujeres con vejiga hiperactiva: historia clínica, diario miccional y estudio urodinámico

Actas urologicas españolas, 2015-01, Vol.39 (1), p.40-46

2015

Volltextzugriff (PDF)

Crystalline silicon solar module technology: Towards the 1 € per watt-peak goal

Progress in photovoltaics, 2009-05, Vol.17 (3), p.199-209

2009

Volltextzugriff (PDF)

Nuevas inmunoterapias en el cáncer de vejiga no músculo-invasivo de alto riesgo: estado actual y perspectivas de futuro

Actas urologicas españolas, 2020-11, Vol.44 (9), p.574-585

2020

Volltextzugriff (PDF)

Iron Overload Increases Oxidative Stress and Decreases Clonogenic Capacity of Cells in MDS Patients: Can be Restored after Deferasirox Treatment?

Leukemia research, 2017-04, Vol.55, p.S161-S162

2017

Volltextzugriff (PDF)

Leucemias agudas

Medicine - programa de formación médica continuada acreditado, 2016-11, Vol.12 (21), p.1201-1212

2016

Volltextzugriff (PDF)

New immunotherapies for high-risk non-muscle invasive bladder cancer: Current state and future perspectives

Actas urológicas españolas (English ed.), 2020-11, Vol.44 (9), p.574-585

2020

Volltextzugriff (PDF)

DNA Repair Genes Transcriptome in Chronic Myelomonocytic Leukemia

Leukemia research, 2017-04, Vol.55, p.S100-S100

2017

Volltextzugriff (PDF)

118 A PHASE 2 STUDY OF AZACITIDINE AND EPOETIN-BETA IN UNTREATED RBC-TRANSFUSION DEPENDENT LOWER-RISK MDS PATIENTS

Leukemia research, 2015-04, Vol.39, p.S61-S61

2015

Volltextzugriff (PDF)

171 A TWO-STEP APPROACH FOR THE ANALYSIS OF SPLICING GENES IN MYELODYSPLASTIC SYNDROMES WITH RING SIDEROBLASTS

Leukemia research, 2015-04, Vol.39, p.S87-S87

2015

Volltextzugriff (PDF)

207 HIGH RISK MDS PATIENTS SUITABLE FOR ALLOGENEIC TRANSPLANT: IMPACT ON TREATMENT SELECTED (AZA OR CHEMOTHERAPY) ON OUTCOME. SINGLE EXPERIENCE CENTER

Leukemia research, 2015-04, Vol.39, p.S103-S104

2015

Volltextzugriff (PDF)

206 IMPACT OF TP53 MUTATION ON OUTCOME OF MDS PATIENTS UNDERGOING ALLOGENEIC STEM CELL TRANSPLANT (HSCT). GESMD STUDY

Leukemia research, 2015-04, Vol.39, p.S102-S103

2015

Volltextzugriff (PDF)

244 MYELOFIBROSIS (MF) AS A PROGNOSTIC TOOL FOR OVERALL SURVIVAL IN MYELODYSPLASTIC SYNDROMES: A PROSPECTIVE EVALUATION INCLUDING MUTATIONAL ANALYSIS BY NEXT GENERATION SEQUENCING (NGS)

Leukemia research, 2015-04, Vol.39, p.S121-S122

2015

Volltextzugriff (PDF)

P-234 Mesenchymal stromal cells from MDS with 5q- show different genetic and epigenetic changes compared to those from other low-risk MDS

Leukemia research, 2013-05, Vol.37, p.S128-S129

2013

Volltextzugriff (PDF)

What are the patient’s understanding about fecal and urinary incontinence management?

European urology, 2022-02, Vol.81, p.S656-S657

2022

Volltextzugriff (PDF)

C013 Genomic aberrations observed in mesenchymal stem cells from 5q-syndrome could be involved in the pathophysiology of the disease

Leukemia research, 2009-05, Vol.33, p.S38-S39

2009

Volltextzugriff (PDF)

308 HIDDEN MDS: A PROSPECTIVE STUDY TO CONFIRM OR EXCLUDE MDS IN PATIENTS WITH ANEMIA OF UNCERTAIN ETIOLOGY

Leukemia research, 2015-04, Vol.39, p.S153-S153

2015

Volltextzugriff (PDF)

298 Chromosome 7 abnormalities in MDS

Leukemia research, 2011, Vol.35, p.S117-S118

2011

Volltextzugriff (PDF)

64 A retrospective time-dependent comparative analysis of the impact of lenalidomide on outcomes in lower risk MDS with chromosome 5q deletion

Leukemia research, 2011, Vol.35, p.S24-S24

2011

Volltextzugriff (PDF)

297 Prognostic impact of severe thrombocytopenia in low risk myelodysplastic syndrome

Leukemia research, 2011, Vol.35, p.S117-S117

2011

Volltextzugriff (PDF)

Topic: AS04-MDS Biology and Pathogenesis/AS04b-Clonal diversity & evolution: LONG-TERM MUTATIONAL DYNAMICS IN DEL(5Q) MDS PATIENTS EARLY TREATED WTIH LENALIDOMIDE (SINTRAREV CLINICAL TRIAL). SAFE AND EFFECITIVE APPROACH REGARDING CLONAL EVOLUTION?

Leukemia research, 2023-05, Vol.128, p.107180, Article 107180

2023

Volltextzugriff (PDF)

P136 Allogenic stem cell transplant in MDS: results of the Spanish registry

Leukemia research, 2009-05, Vol.33, p.S138-S139

2009

Volltextzugriff (PDF)

P030 Prognostic impact on survival of an unsuccessful conventional cytogenetic study in patients with myelodysplastic syndromes (MDS)

Leukemia research, 2009-05, Vol.33, p.S75-S76

2009

Volltextzugriff (PDF)

Mesenchymal Stromal Cells From Myelodysplastic Syndrome Patients Show Lower DICER1 and DROSHA Expression, as Well as Decreased Mir-155 and Mir-181a MicroRNA Expression, When Compared with Healthy Controls

Blood, 2010-11, Vol.116 (21), p.397-397

2010

Volltextzugriff (PDF)

P029 Prognostic relevance of specific chromosomal abnormalities in chronic myelomonocytic leukemia

Leukemia research, 2009-05, Vol.33, p.S74-S75

2009

Volltextzugriff (PDF)

C005 Prognostic impact of the proportion of aberrant metaphases in patients with a primary myelodysplastic syndrome

Leukemia research, 2009-05, Vol.33, p.S33-S34

2009

Volltextzugriff (PDF)

1 – 25 von 191

Suche als RSS-Feed

Aktive Filter

ThemaScience & Technology

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(120)
Mit Volltextzugriff
(105)

Publikationsform

Sprache

Erscheinungsjahr

n.n

Thema

Humans
(74)
Male
(32)
Female
(29)
Hematology, Oncology And Palliative Medicine
(24)
Middle Aged
(20)
Adult
(16)
Aged
(16)
Urology
(16)
Old Medline
(11)
Adolescent
(10)
Biological And Medical Sciences
(10)
Child
(10)
Medical Sciences
(10)
Aged, 80 And Over
(8)
Prognosis
(8)
Spain
(8)
Trasplante Renal
(8)
Animals
(7)
Retrospective Studies
(7)
Child, Preschool
(6)

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Análisis coste-efectividad de las principales herramientas diagnósticas en mujeres con vejiga hiperactiva: historia clínica, diario miccional y estudio urodinámico

Crystalline silicon solar module technology: Towards the 1 € per watt-peak goal

Nuevas inmunoterapias en el cáncer de vejiga no músculo-invasivo de alto riesgo: estado actual y perspectivas de futuro

Iron Overload Increases Oxidative Stress and Decreases Clonogenic Capacity of Cells in MDS Patients: Can be Restored after Deferasirox Treatment?

Leucemias agudas

New immunotherapies for high-risk non-muscle invasive bladder cancer: Current state and future perspectives

DNA Repair Genes Transcriptome in Chronic Myelomonocytic Leukemia

118 A PHASE 2 STUDY OF AZACITIDINE AND EPOETIN-BETA IN UNTREATED RBC-TRANSFUSION DEPENDENT LOWER-RISK MDS PATIENTS

171 A TWO-STEP APPROACH FOR THE ANALYSIS OF SPLICING GENES IN MYELODYSPLASTIC SYNDROMES WITH RING SIDEROBLASTS

207 HIGH RISK MDS PATIENTS SUITABLE FOR ALLOGENEIC TRANSPLANT: IMPACT ON TREATMENT SELECTED (AZA OR CHEMOTHERAPY) ON OUTCOME. SINGLE EXPERIENCE CENTER

206 IMPACT OF TP53 MUTATION ON OUTCOME OF MDS PATIENTS UNDERGOING ALLOGENEIC STEM CELL TRANSPLANT (HSCT). GESMD STUDY

244 MYELOFIBROSIS (MF) AS A PROGNOSTIC TOOL FOR OVERALL SURVIVAL IN MYELODYSPLASTIC SYNDROMES: A PROSPECTIVE EVALUATION INCLUDING MUTATIONAL ANALYSIS BY NEXT GENERATION SEQUENCING (NGS)

P-234 Mesenchymal stromal cells from MDS with 5q- show different genetic and epigenetic changes compared to those from other low-risk MDS

What are the patient’s understanding about fecal and urinary incontinence management?

C013 Genomic aberrations observed in mesenchymal stem cells from 5q-syndrome could be involved in the pathophysiology of the disease

308 HIDDEN MDS: A PROSPECTIVE STUDY TO CONFIRM OR EXCLUDE MDS IN PATIENTS WITH ANEMIA OF UNCERTAIN ETIOLOGY

298 Chromosome 7 abnormalities in MDS

64 A retrospective time-dependent comparative analysis of the impact of lenalidomide on outcomes in lower risk MDS with chromosome 5q deletion

297 Prognostic impact of severe thrombocytopenia in low risk myelodysplastic syndrome

Topic: AS04-MDS Biology and Pathogenesis/AS04b-Clonal diversity & evolution: LONG-TERM MUTATIONAL DYNAMICS IN DEL(5Q) MDS PATIENTS EARLY TREATED WTIH LENALIDOMIDE (SINTRAREV CLINICAL TRIAL). SAFE AND EFFECITIVE APPROACH REGARDING CLONAL EVOLUTION?

P136 Allogenic stem cell transplant in MDS: results of the Spanish registry

P030 Prognostic impact on survival of an unsuccessful conventional cytogenetic study in patients with myelodysplastic syndromes (MDS)

Mesenchymal Stromal Cells From Myelodysplastic Syndrome Patients Show Lower DICER1 and DROSHA Expression, as Well as Decreased Mir-155 and Mir-181a MicroRNA Expression, When Compared with Healthy Controls

P029 Prognostic relevance of specific chromosomal abnormalities in chronic myelomonocytic leukemia

C005 Prognostic impact of the proportion of aberrant metaphases in patients with a primary myelodysplastic syndrome

Aktive Filter

Suchergebnisse filtern